Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report

RATIONALE: In estrogen receptor-positive HER2-negative (ER+HER2-) metastatic breast cancer, chemotherapy should be offered only to patients who develop endocrine resistance or have a rapid disease progression. However, the correct sequence of chemotherapy administration is still debated. PATIENT CON...

Descripción completa

Detalles Bibliográficos
Autores principales: Barchiesi, Giacomo, Krasniqi, Eriseld, Barba, Maddalena, Giulia, Marina Della, Pizzuti, Laura, Massimiani, Gioia, Ciliberto, Gennaro, Vici, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750334/
https://www.ncbi.nlm.nih.gov/pubmed/31517852
http://dx.doi.org/10.1097/MD.0000000000017135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750334/
https://www.ncbi.nlm.nih.gov/pubmed/31517852
http://dx.doi.org/10.1097/MD.0000000000017135

Ejemplares similares